Health Advance Inc. (HADV)
 OTCMKTS  · Delayed Price · Currency is USD  
0.0003
 0.00 (0.00%)
  At close: Oct 29, 2025
Health Advance Statistics
Total Valuation
Health Advance has a market cap or net worth of 292,241.
| Market Cap | 292,241 | 
| Enterprise Value | n/a | 
Important Dates
| Earnings Date | n/a | 
| Ex-Dividend Date | n/a | 
Share Statistics
Health Advance has 974.14 million shares outstanding.
| Current Share Class | 974.14M | 
| Shares Outstanding | 974.14M | 
| Shares Change (YoY) | n/a | 
| Shares Change (QoQ) | n/a | 
| Owned by Insiders (%) | n/a | 
| Owned by Institutions (%) | n/a | 
| Float | 955.72M | 
Valuation Ratios
| PE Ratio | n/a | 
| Forward PE | n/a | 
| PS Ratio | n/a | 
| PB Ratio | -1.76 | 
| P/TBV Ratio | n/a | 
| P/FCF Ratio | n/a | 
| P/OCF Ratio | n/a | 
| PEG Ratio | n/a | 
Enterprise Valuation
| EV / Earnings | n/a | 
| EV / Sales | n/a | 
| EV / EBITDA | n/a | 
| EV / EBIT | n/a | 
| EV / FCF | n/a | 
Financial Position
| Current Ratio | n/a | 
| Quick Ratio | n/a | 
| Debt / Equity | n/a | 
| Debt / EBITDA | n/a | 
| Debt / FCF | n/a | 
| Interest Coverage | n/a | 
Financial Efficiency
| Return on Equity (ROE) | n/a | 
| Return on Assets (ROA) | n/a | 
| Return on Invested Capital (ROIC) | n/a | 
| Return on Capital Employed (ROCE) | n/a | 
| Revenue Per Employee | n/a | 
| Profits Per Employee | n/a | 
| Employee Count | n/a | 
| Asset Turnover | n/a | 
| Inventory Turnover | n/a | 
Taxes
| Income Tax | n/a | 
| Effective Tax Rate | n/a | 
Stock Price Statistics
The stock price has decreased by -66.67% in the last 52 weeks. The beta is 0.74, so Health Advance's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 | 
| 52-Week Price Change | -66.67% | 
| 50-Day Moving Average | 0.00 | 
| 200-Day Moving Average | 0.00 | 
| Relative Strength Index (RSI) | 44.84 | 
| Average Volume (20 Days) | 10,966,564 | 
Short Selling Information
| Short Interest | n/a | 
| Short Previous Month | n/a | 
| Short % of Shares Out | n/a | 
| Short % of Float | n/a | 
| Short Ratio (days to cover) | 0.00 | 
Income Statement
| Revenue | n/a | 
| Gross Profit | n/a | 
| Operating Income | -32,225 | 
| Pretax Income | -32,220 | 
| Net Income | -32,220 | 
| EBITDA | n/a | 
| EBIT | -32,225 | 
| Earnings Per Share (EPS) | -0.00 | 
Balance Sheet
| Cash & Cash Equivalents | n/a | 
| Total Debt | n/a | 
| Net Cash | n/a | 
| Net Cash Per Share | n/a | 
| Equity (Book Value) | -166,164 | 
| Book Value Per Share | -0.01 | 
| Working Capital | n/a | 
Cash Flow
| Operating Cash Flow | -33,863 | 
| Capital Expenditures | n/a | 
| Free Cash Flow | n/a | 
| FCF Per Share | n/a | 
Margins
| Gross Margin | n/a | 
| Operating Margin | n/a | 
| Pretax Margin | n/a | 
| Profit Margin | n/a | 
| EBITDA Margin | n/a | 
| EBIT Margin | n/a | 
| FCF Margin | n/a | 
Dividends & Yields
Health Advance does not appear to pay any dividends at this time.
| Dividend Per Share | n/a | 
| Dividend Yield | n/a | 
| Dividend Growth (YoY) | n/a | 
| Years of Dividend Growth | n/a | 
| Payout Ratio | n/a | 
| Buyback Yield | -40.78% | 
| Shareholder Yield | -40.78% | 
| Earnings Yield | -11.03% | 
| FCF Yield | n/a | 
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a | 
| Lynch Upside | n/a | 
| Graham Number | n/a | 
| Graham Upside | n/a | 
Stock Splits
The last stock split was on February 15, 2013. It was a forward split with a ratio of 10.
| Last Split Date | Feb 15, 2013 | 
| Split Type | Forward | 
| Split Ratio | 10 | 
Scores
| Altman Z-Score | n/a | 
| Piotroski F-Score | n/a |